Table 2 Predicting inefficacy
Predictor1 year2 years
Unadjusted OR (95% CI)p ValueAdjusted OR (95% CI)p ValueUnadjusted OR (95% CI)p ValueAdjusted OR (95% CI)p Value
SE positive5.83 (1.33 to 25.61)0.025.88 (1.32 to 26.25)0.023.04 (1.27 to 7.27)0.013.04 (1.21 to 7.62)0.02
  • MTX, methotrexate; SE, shared epitope.

  • This table illustrates the odds of stopping MTX for inefficacy—OR (95% CI) displayed as unadjusted and adjusted for age, gender, symptom duration and steroid use at baseline.